Nevertheless, our results not only support the use of ITGB2 and the newly identified SCLC-ITGB2-sig as diagnostic markers for SCLC, but also as targets to develop therapeutic strategies against this extremely aggressive type of LC. Here, ITGB2 is linked to laryngotracheoesophageal cleft.